Table 3.
CD24 (–) n (%) | CD24 (+) n (%) | P-value | |
---|---|---|---|
All cases (n = 119) | |||
HIF-1α | |||
(–) | 54 (57.4%) | 40 (42.6%) | <0.001 |
(+) | 4 (16.0%) | 21 (84.0%) | |
HIF-2α | |||
(–) | 45 (60.8%) | 29 (39.2%) | 0.002 |
(+) | 13 (28.9%) | 32 (71.1%) | |
Diffuse type (n = 61) | |||
HIF-1α | |||
(–) | 32 (68.1%) | 15 (31.9%) | 0.002 |
(+) | 3 (21.4%) | 11 (78.6%) | |
HIF-2α | |||
(–) | 24 (68.6%) | 11 (31.4%) | 0.040 |
(+) | 11 (42.3%) | 15 (57.7%) | |
Intestinal type (n = 58) | |||
HIF-1α | |||
(–) | 22 (46.8%) | 25 (53.2%) | 0.021 |
(+) | 1 (9.1%) | 10 (90.9%) | |
HIF-2α | |||
(–) | 21 (53.8%) | 18 (46.2%) | 0.001 |
(+) | 2 (10.5%) | 17 (89.5%) |